While it is anticipated that DNMT inhibition will prevent hypermethylation, recent genetic studies have indicated that severe DNMT activity inhibition may result in DNA hypomethylation, genomic instability, and the early development of cancers like sarcomas and T-cell lymphomas [122,123]. This evidence concerns the gene DNMT1 and T-cell non-Hodgkin lymphoma.